Mauro, David J.
Universitat Autònoma de Barcelona · Oslo University Hospital · Merck & Co., Inc., Rahway, NJ, USA (United States) · Royal Marsden NHS Foundation Trust · Karolinska University Hospital · Seoul National University · Yonsei University · New Cross Hospital · Concord Repatriation General Hospital · Asan Medical Center · Samsung Medical Center · University of Ulsan · National Cancer Center · Royal Marsden Hospital · Vall d'Hebron Hospital Universitari · Yonsei Cancer Hospital · Martin Luther University Halle-Wittenberg
3 papers on CoChat
Most cited papers
- Verified
Expression of Epiregulin and Amphiregulin and K-ras Mutation Status Predict Disease Control in Metastatic Colorectal Cancer Patients Treated With Cetuximab
Khambata-Ford, S., Garrett, C. R., Meropol, N. J., Basik, M., Harbison, C. T., Wu, S., Wong, T. W., Huang, X., Takimoto, C. H., Godwin, A. K., et al. (2007) · Journal of Clinical Oncology
Colorectal Cancer Treatments and StudiesHER2/EGFR in Cancer Research
Cited by 1,125
- Verified
A Randomized Phase II/III Study of Dalotuzumab in Combination With Cetuximab and Irinotecan in Chemorefractory,KRAS Wild-Type, Metastatic Colorectal Cancer
Sclafani, F., Kim, T. Y., Cunningham, D., Kim, T. W., Tabernero, J., Schmoll, H. J., Roh, J. K., Kim, S. Y., Park, Y. S., Guren, T. K., et al. (2015) · Journal of the National Cancer Institute
Colorectal Cancer Treatments and StudiesGrowth Hormone and Insulin-like Growth Factors
Cited by 92
- Verified
Germline Polymorphisms in Genes Involved in the IGF1 Pathway Predict Efficacy of Cetuximab in Wild-type KRAS mCRC Patients
Winder, T., Zhang, W., Yang, D., Ning, Y., Bohanes, P., Gerger, A., Wilson, P. M., Pohl, A., Mauro, D. J., Langer, C., et al. (2010) · Clinical Cancer Research
Colorectal Cancer Treatments and StudiesGenetic factors in colorectal cancer
Cited by 46
Go further with a free account
Verify every reference, keep papers in a library, and ask questions across them.
Sign up - it is free